Aug 18, 2026 8:30 am EDT Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
Aug 11, 2026 8:30 am EDT Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
Jul 14, 2026 8:30 am EDT The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
Jul 7, 2026 9:00 am EDT A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
Jun 25, 2026 8:30 am EDT Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
Jun 15, 2026 8:30 am EDT Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
Jun 8, 2026 8:30 am EDT Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
May 27, 2026 10:36 am EDT UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026 8:30 am EDT Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
